Abbott Diet Pill to Face Tougher Warnings from European Drug Agency

.

Abbott Diet Pill to Face Tougher Warnings from European Drug Agency

European regulatory authorities on Thursday said an Abbott Laboratories (ABT) diet pill should be banned from sale in the market, issuing tougher warnings for the drug because the drug poses high risks of stroke and heart attack.

The warning was conveyed after a study of 10,000 patients suggested it put them at a higher risk for heart disease.

The study revealed 11.4% of those who used Meridia as a medication faced a cardiovascular event such as a heart attack, compared with 10% of patients who received a fake pill.

This medicine is sold in Europe under the brand-names Reductil, Reduxade, Zelium and other names; and as Meridia in the U. S.

The warning for not to use Meridia is to include patients with a history of problems as Coronary artery disease, heart attack, transient ischemic attack, Arrhythmia, Congestive heart failure, Peripheral arterial disease, uncontrolled hypertension.

The agency's decision will now get passed to the European Commission for review.

The FDA said Abbott has agreed to update the label bearing “recommended the drug shouldn't be used in patients with a history of heart disease, “and further plans to convene an advisory committee meeting to further discuss the safety and risks with Meridia.


Latest News

Good News for the Diabetic: FDA Approved Mobile Medical Application for Sharing
Fifth Death Related to Flu in Bay Area; The  First in Napa County
Ship Industry
For Bill Erbey Its Time to Pay Back
Union Organizers Files Lawsuit Against American Airlines
Venus In Past Had Vast Oceans of Liquid Carbon Dioxide, Say Researchers
Bill and Melinda Gates Have Long term Charity Plans but Now It’s Time for Super
Wynn Everett Casino Design Have Alterations with More luxury rooms and Lesser Pa
Alert Issued after Adult Film Actor became infected with HIV
Out Look for Oil Future Remains Weak Though Brent Crude Moves Above $48
BOJ Trimmed Its Inflation Forecast and Expanded Loan Scheme Aimed at Boosting Le
Layoff Reports at DreamWorks Animation following Changes in Higher Management Le